Company Overview of Nura Inc.
Nura, Inc., a development stage biotechnology company, engages in the development and discovery of therapeutics for behavioral disorders and neurodegenerative diseases. The company focuses on behavioral and neurodegenerative diseases with particular emphasis on G Protein-coupled receptor (GPCR) and phosphodiesterase (PDE) targets expressed in the brain. Its programs include schizophrenia, pain, and attention-deficit hyperactivity disorder. The company was founded in 2003 and is based in Seattle, Washington. As of September 7, 2006, Nura, Inc. operates as a subsidiary of Omeros Corporation.
1124 Columbia Street
Seattle, WA 98104
Founded in 2003
Key Executives for Nura Inc.
Similar Private Companies By Industry
|Sound Pharmaceuticals, Inc.||United States|
|Danbury Pharmacal Inc.||United States|
|Trutek Corp.||United States|
|Tragara Pharmaceuticals, Inc.||United States|
|LQ3 Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Nura Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.